New Key Statistics Module, Z-Score and F-Score
NAS:CSCI Key Ratios
| Market Cap $ M | 13.16 |
| Enterprise Value $ M | 1.79 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.25 |
| Price/Sales | 1.32 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9.00 |
| EPS (TTM) $ | -6.00 |
| Beneish M-Score | -3.43 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.11 |
| EV-to-EBITDA | -0.12 |
| PEG | -- |
| Shares Outstanding M | 3.15 |
| Net Margin (%) | -194.74 |
| Operating Margin % | -174.52 |
| Pre-tax Margin (%) | -188.86 |
| Quick Ratio | 2.54 |
| Current Ratio | 2.88 |
| ROA % (ttm) | -48.77 |
| ROE % (ttm) | -100.42 |
| ROIC % (ttm) | -95.40 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.25 |
CSCI Number of Guru Trades
CSCI Volume of Guru Trades
Gurus Latest Trades with NAS:CSCI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CSCI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cosciens Biopharma Inc Insider Transactions
No Available Data
News about NAS:CSCI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers